Pediatric Neurology Briefs
Published 1995 | Version v1.0.0
Journal Article Open

Treatment Duration for Absence Epilepsy

Creators

Abstract

The effects of 6 months of treatment followed by a 5- to 6-week withdrawal period of ethosuximide (ESM) in 3 children, ages 5, 10, and 10 years, with new onset absence epilepsy are reported from the Departments of Neurology, State University of New York at Stony Brook, and the Division of Child Neurology, Schneider Childrens Hospital and Albert Einstein College of Medicine, New York.

Files

PNB-9-56-a.pdf

Files (1.3 MB)

Name Size Download all
md5:f1294c5fd4459a737fa57fe23f5101a1
1.3 MB Preview Download

Additional details

Identifiers

Other
PNB-9-56-a

Dates

Created
1995
When the item was originally created.